Zobrazeno 1 - 10
of 53
pro vyhledávání: '"Dong Ming Zhou"'
Publikováno v:
Hereditas, Vol 161, Iss 1, Pp 1-14 (2024)
Abstract Background The therapeutic potential of oncolytic measles virotherapy has been demonstrated across various malignancies. However, the effectiveness against human breast cancer (BC) and the underlying mechanisms of the recombinant measles vir
Externí odkaz:
https://doaj.org/article/99278f8950134485a9c04f1c492818e8
Autor:
Chu-di Zhang, Li-hong Jiang, Xue Zhou, Yong-ping He, Ye Liu, Dong-ming Zhou, Yao Lv, Ben-qing Wu, Zheng-yan Zhao
Publikováno v:
Translational Oncology, Vol 39, Iss , Pp 101812- (2024)
Background: Malignancies with BRCA1/2 deficiencies are particularly sensitive to PARP inhibitors. Thus, combining PARP inhibitors with agents that impair DNA damage repair to treat BRCA1/2 wild-type PDAC could broaden the clinical use of these promis
Externí odkaz:
https://doaj.org/article/659d894b4a5e48ee9d39b18d38a42a5e
Autor:
Kan Li, Liu Yao, Jin Wang, Hao Song, Yan-hong Zhang, Xue Bai, Kai Zhang, Dong-ming Zhou, Ding Ai, Yi Zhu
Publikováno v:
Signal Transduction and Targeted Therapy, Vol 7, Iss 1, Pp 1-3 (2022)
Externí odkaz:
https://doaj.org/article/6662dd4b61f24814aedafbe953365dbc
Autor:
Wei-Tao Dou, Pei-Hong Tong, Man Xing, Jiao-Jiao Liu, Xi-Le Hu, James, Tony D., Dong-Ming Zhou, Xiao-Peng He
Publikováno v:
Journal of the American Chemical Society; 7/31/2024, Vol. 146 Issue 30, p21017-21024, 8p
Autor:
Chu-di Zhang, Yi-long Wang, Dong-ming Zhou, Meng-ying Zhu, Yao Lv, Xiao-qiang Hao, Chu-fan Qu, Yi Chen, Wei-zhong Gu, Ben-qing Wu, Pei-chun Chen, Zheng-yan Zhao
Publikováno v:
Translational Oncology, Vol 14, Iss 7, Pp 101091- (2021)
The potential therapeutic effects of oncolytic measles virotherapy have been verified against plenty of malignancies. However, the oncolytic effects and underlying mechanisms of the recombinant Chinese measles virus vaccine strain Hu191 (rMV-Hu191) a
Externí odkaz:
https://doaj.org/article/fe3bb32e376046aeaba5ff51d5a19501
Autor:
Wei-Tao Dou, Xiang Wang, Tingting Liu, Suwen Zhao, Jiao-Jiao Liu, Yao Yan, Jun Li, Chi-Yu Zhang, Adam C. Sedgwick, He Tian, Jonathan L. Sessler, Dong-Ming Zhou, Xiao-Peng He
Publikováno v:
Chem. 8:1750-1761
Publikováno v:
Drug Design, Development and Therapy. 16:1983-1993
Xiao-Feng Lv,* Dong-Ming Zhou, Xiao-Hong Sun,* Ze Zhao Department of Trauma, First Affiliated Hospital of Baotou Medical College, Inner Mongolia University of Science and Technology, Baotou, Inner Mongolia Autonomous Region, 014010, Peopleâ
Autor:
Yi-long Wang, Ben-qing Wu, Weizhong Gu, Pei-chun Chen, Zhengyan Zhao, Meng-ying Zhu, Xiao-qiang Hao, Jinhu Wang, Chu-di Zhang, Yao Lv, Jin-gan Lou, Dong-ming Zhou, Hongqiang Shen
Publikováno v:
Gastric Cancer
Background DDP-based chemotherapy is one of the first-line treatment in GC. However, the therapeutic efficacy of DDP is limited due to side effects. Therefore, it is of great significance to develop novel adjuvants to synergize with DDP. We had demon
Publikováno v:
Aging (Albany NY)
We investigated the protective effects and mechanism of action of metformin on high glucose-induced smooth muscle cell proliferation and migration. Vascular smooth muscle cells (VSMCs) were subjected to a series of concentrations (0-10 mM) of metform
Publikováno v:
Journal of Cellular and Molecular Medicine
Endothelial progenitor cells (EPCs) have emerged as a promising therapeutic choice for thrombi recanalization. However, this role of EPCs is confined by some detrimental factors. The aim of this study was to explore the role of the miR‐9‐5p in re